Chinese stocks ended higher, supported by home appliance and pharma stocks. Despite the impact of China's ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

The signs of WuXi AppTec's performance rebound were evident last quarter, with its net profit soaring 91 percent to CNY2.9 ...

Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...

The competition between U.S. and Chinese biotech companies is particularly fierce in one field: CRISPR gene editing. Here are ...

Chinese firms can accelerate clinical trials and bring their drugs to market faster with more supportive policies, ...

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

According to data from DealForma, as reported by CNBC, around 30% of Big Pharma deals with at least $50 million upfront in 2024 included Chinese companies. This was up from 20% the year before and ...

What will be the impact of Trump's tariffs on healthcare? What will this mean for patients? Where do we get our medical ...